Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
13.4M
-
Shares change
-
-184K
-
Total reported value, excl. options
-
$4.96M
-
Value change
-
-$113K
-
Number of buys
-
12
-
Number of sells
-
-14
-
Price
-
$0.37
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q1 2025
45 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q1 2025.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.4M shares
of 52.3M outstanding shares and own 25.66% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.18M shares), RENAISSANCE TECHNOLOGIES LLC (2.08M shares), VANGUARD GROUP INC (1.86M shares), BlackRock, Inc. (958K shares), Mink Brook Asset Management LLC (808K shares), GEODE CAPITAL MANAGEMENT, LLC (431K shares), WITTENBERG INVESTMENT MANAGEMENT, INC. (274K shares), RBF Capital, LLC (250K shares), CITADEL ADVISORS LLC (211K shares), and STATE STREET CORP (169K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.